2022 annual financial data

Radiopharm Theranostics Limited - American Depositary Shares 2022 Operating margin

Radiopharm Theranostics Limited - American Depositary Shares 2022 operating mar…

Direct answer

Operating margin was -225,527.71%.

Operating income was -19,916,352 AUD and net income was -30,338,979 AUD.
Operating cash flow was -9,915,654 AUD.
Alpha Vantage

Get free Radiopharm Theranostics Limited - American Depositary Shares email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
8,831 AUD
Operating income
-19,916,352 AUD
Net income
-30,338,979 AUD
Operating cash flow
-9,915,654 AUD

Explore related company data

View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Radiopharm Theranostics Limited - American Depositary Shares financial years